Sign in
CompletedNo phase

HSAT for OSA Management in Children

Key facts

Who runs it
Children's Hospital of Philadelphia
Where
Philadelphia, United StatesSee the site
Trial code
Status
Completed
People taking part
62 people enrolled
Started
1 Dec 2022
Ended
17 Sept 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Home sleep apnea test
  • PSG
Record updated
14 October 2025

Who can take part

Age
5 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Male and female children age 5-12 years old inclusive
  • History of adenotonsillectomy for OSA

Who cannot take part

  • Children with a history of hypoventilation or hypoxemia or who require supplemental oxygen or positive airway pressure during sleep
  • Children with a tracheostomy or tracheocutaneous fistula
  • Children who live in a facility without their parent

Where in United States

  • Children's Hospital of PhiladelphiaPhiladelphia, United States

About the trial

What the trial wants to find out

This clinical trial will compare the diagnostic accuracy of type II HSAT with PSG for determining OSA status following treatment with adenotonsillectomy in children

The 2 groups in the trial

  • HSAT prior to clinical sleep studyTreatment being tested

    Participants will be randomized to undergo HSAT before receiving their clinical, in-lab polysomnography

    Treatment: Home sleep apnea test

  • PSG first Participants will be randomExisting treatment, for comparison

    Participants will be randomized to undergo HSAT after receiving their clinical, in-lab polysomnography.

    Treatment: PSG

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Home Sleep Apnea Testing for the Evaluation of Obstructive Sleep Apnea in Children Following Management With Adenotonsillectomy
Record updated
14 October 2025